Chapter 2 Clinical Features of the Mitochondrial Encephalomyopathies

Blue Books of Practical Neurology

Volumn 26, Issue C, 2002, Pages 35-68

  Hart, Paul E ^a   De Vivo, Darryl C ^a   Schapira, Anthony H V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957148063     PISSN: 18773419     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-3419(09)70061-3     Document Type: Article

References (276)

1. Leonard J.V., and Schapira A. Mitochondrial respiratory chain disorders I. Lancet 355 (2000) 299-305
2. Leonard J.V., and Schapira A. Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet 355 (2000) 389-395
3. De Vivo D.C. The expanding clinical spectrum of mitochondrial diseases. Brain Develop 15 (1993) 1-22
4. De Vivo D.C., Hirano M., and DiMauro S. Mitochondrial Disorders. In: Moser H.W. (Ed). Handbook of Clinical Neurology 22(66): Neurodystrophies and Neurolipidoses. (1996), Elsevier, Amsterdam 389-446
5. Schon E.A., Bonilla E., Di Mauro S., et al. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 29 (1997) 131-149
6. Servidei S. Mitochondrial encephalomyopathies: gene mutation. Neuromuscul Disord 8 (1998) 18-19
7. Wallace D.C. Mitochondrial diseases in mouse and man. Science 283 (1999) 1482-1488
8. DiMauro S., Bonilla E., Davidson M., et al. Mitochondria in neuromuscular disorders. Biochim Biophys Acta 1366 (1998) 199-210
9. Morgan-Hughes J.A., and Hanna M.G. Mitochondrial encephalomyopathies: the enigma of genotype versus phenotype. Biochim Biophys Acta 1410 (1999) 125-145
10. Pons R., and De Vivo D.C. Mitochondrial disease. Curr Treat Neurol 3 (2001) 271-288
11. Majamaa K., Moilanen J.S., Uimonen S., et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and stroke like episodes: prevalence of the mutation in an adult population. Am J Hum Genet 63 (1998) 447-454
12. Chinnery P.F., Johnson M.A., Wardell T.M., et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 48 (2000) 188-193
13. Gerbitz K.D., van den Ouweland J.M.W., Maasen J.A., et al. Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta 1271 (1995) 253-260
14. Maassen J.A., and Kadowaki T. Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 39 (1996) 375-382
15. Luft R., Ikkos D., Palmieri G., et al. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control; a correlated clinical, biochemical, and morphological study. J Clin Invest 41 (1962) 1776-1804
16. DiMauro S., Bonilla E., Lee C.P., et al. Luft's disease: further biochemical and ultrastructural studies of skeletal muscle in the second case. J Neurol Sci 27 (1976) 217-232
17. Morgan-Hughes J.A., Hayes D.J., Clark J.B., et al. Mitochondrial encephalomyopathies: biochemical studies in two cases revealing defects in the respiratory chain. Brain 105 (1982) 553-582
18. Olson W., Engel W.K., Walsh G.O., et al. Oculocraniosomatic neuromuscular disease with "ragged-red" fibers; histochemical and ultrastructural changes in limb muscles of a group of patients with idiopathic progressive external ophthalmoplegia. Arch Neurol 26 (1972) 193-211
19. Morgan-Hughes J.A., and Mair W.G. Atypical muscle mitochondria in oculoskeletal myopathy. Brain 96 (1973) 215-224
20. Engel W.K., and Cunningham C.G. Rapid examination of muscle tissue; an improved trichrome stain method for fresh-frozen biopsy sections. Neurology 13 (1963) 919-923
21. Shapira Y., Harel S., and Russell A. Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects of oxidative metabolism. Isr J Med Sci 13 (1977) 161-164
22. Fukuhara N., Tokiguchi S., Shirakawa K., et al. Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities): disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature. J Neurol Sci 47 (1980) 117-133
23. DiMauro S., Bonilla E., Zeviani M., et al. Mitochondrial myopathies. Ann Neurol 17 (1985) 521-538
24. Attardi G., Yoneda M., and Chomyn A. Complementation and segregation behaviour of disease causing mitochondrial DNA mutations in cellular model systems. Biochim Biophys Acta 1271 (1995) 241-248
25. Chinnery P.F., Howell N., Lightowlers R.N., et al. Molecular pathology of MELAS and MERRF: the relationship between mutation load and clinical phenotypes. Brain 120 (1997) 1713-1721
26. Warner T.T., and Schapira A. Genetic counselling and mitochondrial diseases. Curr Opin Neurol 10 (1997) 408-412
27. Cock H.R., Cooper J.M., and Schapira A.H. Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. J Neurol Sci 165 (1999) 10-17
28. Sparaco M., Bonilla E., DiMauro S., et al. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 52 (1993) 1-10
29. Tanno Y., Yoneda M., Tanaka K., et al. Uniform tissue distribution of tRNA(Lys) mutation in mitochondrial DNA in MERRF patients. Neurology 43 (1993) 1198-2000
30. Hammans S.R., Sweeney M.G., Hanna M.G., et al. The mitochondrial DNA transfer RNALeu(UUR) A→G(3243) mutation. A clinical and genetic study. Brain 118 (1995) 721-734
31. Pulkes T., Sweeney M.G., and Hanna M.G. Increased risk of stroke in patients with the A12308G polymorphism in mitochondria. Lancet 356 (2000) 2068-2069
32. El Meziane A., Lehtinen S.K., Hance N., et al. A tRNA suppressor mutation in human mitochondria. Nat Genet 18 (1998) 350-353
33. Berenberg R.A., Pellock J.M., DiMauro S., et al. Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome?. Ann Neurol 1 (1977) 37-54
34. Roberts N.K., Perloff J.K., and Kark R.A. Cardiac conduction in the Kearns-Sayre syndrome (a neuromuscular disorder associated with progressive external ophthalmoplegia, and pigmentary retinopathy). Report of 2 cases and review of 17 published cases. Am J Cardiol 44 (1979) 1396-1400
35. Petty R.K., Harding A.E., and Morgan-Hughes J.A. The clinical features of mitochondrial myopathy. Brain 109 (1986) 915-938
36. Rowland L.P., Blake D.M., Hirano M., et al. Clinical syndromes associated with ragged red fibres. Rev Neurol 147 (1991) 467-473
37. Hammans S.R., Sweeney M.G., Brockington M., et al. Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet 337 (1991) 1311-1313
38. Truong D.D., Harding A.E., Scaravilli F., et al. Movement disorders in mitochondrial myopathies. A study of nine cases with two autopsy studies. Mov Disord 5 (1990) 109-117
39. Quade A., Zierz S., and Klingmuller D. Endocrine abnormalities in mitochondrial myopathy with external ophthalmoplegia. Clin Invest 70 (1992) 396-402
40. Harvey J.N., and Barnett D. Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol 37 (1992) 97-103
41. Holt I.J., Harding A.E., and Morgan-Hughes J.A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331 (1988) 717-719
42. Holt I.J., Harding A.E., Cooper J.M., et al. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 26 (1989) 699-708
43. Moraes C.T., DiMauro S., Zeviani M., et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 320 (1989) 1293-1299
44. 31P-NMR spectroscopy alterations in a migraine patient. J Neurol Sci 104 (1991) 182-189
45. Ballinger S.W., Shoffner J.M., Hadaya E.V., et al. Maternal transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1 (1992) 11-15
46. Zeviani M., Moraes C.T., DiMauro S., et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 38 (1998) 1339-1346
47. Mariotti C., Savarese N., Suomalainen A., et al. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 242 (1995) 304-312
48. Zeviani M., Servidei S., Gellera C., et al. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339 (1989) 309-311
49. Servidei S., Zeviani M., Manfredi G., et al. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology 41 (1991) 1053-1059
50. Suomalainen A., Kaukonen J., Amati P., et al. An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet 9 (1995) 146-151
51. Kaukonen J.A., Amati P., Suomalainen A., et al. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet 58 (1996) 763-769
52. Ohno K., Tanaka M., Sahashi K., et al. Mitochondrial DNA deletions in inherited recurrent myoglobinuria. Ann Neurol 29 (1991) 364-369
53. Blumenthal D.T., Shanske S., Schochet S.S., et al. Myoclonus epilepsy with ragged red fibers and multiple mtDNA deletions. Neurology 50 (1998) 524-525
54. Oldfors A., Larsson N.G., Lindberg C., et al. Mitochondrial DNA deletions in inclusion body myositis. Brain 116 (1993) 325-336
55. Pavlakis S.G., Phillips P.C., DiMauro S., et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 16 (1984) 481-488
56. Gilchrist J.M., Sikirica M., Stopa E., et al. Adult onset MELAS: evidence for involvement of neurones as well as cerebral vasculature in strokelike episodes. Stroke 27 (1996) 1420-1423
57. Koo B., Becker L.E., Chuang S., et al. Mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): clinical, radiological, pathological, and genetic observations. Ann Neurol 34 (1993) 25-32
58. Yoneda M., Tanaka M., Nishikimi M., et al. Pleiotropic molecular defects in energy-transducing complexes in mitochondrial encephalomyopathy. J Neurol Sci 92 (1989) 143-158
59. Johns D.R., Stein A.G., and Wityk R. MELAS syndrome masquerading as herpes simplex encephalitis. Neurology 43 (1993) 2471-2473
60. Sharfstein S.R., Gordon M.F., Libman R.B., et al. Adult-onset MELAS presenting as herpes encephalitis. Arch Neurol 56 (1999) 241-243
61. Briones P., Vilaseca M.A., Cargia-Silva M.T., et al. Congenital disorders of glycosylation (CDG) may be underdiagnosed when mimicking mitochondrial disease. Eur J Paediatr Neurol 5 (2001) 127-131
62. Allard J.C., Tilak S., and Carter A.P. CT and MR of MELAS syndrome. Am J Neuroradiol 9 (1988) 1234-1238
63. Hanna M.G., Nelson I.P., Morgan-Hughes J.A., et al. MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. J Neurol Neurosurg Psychiatry 65 (1998) 512-517
64. Majamaa K., Turkka J., Kärppä M., et al. The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital brain infarct. Neurology 49 (1997) 1331-1334
65. Bogousslavsky J., Regli F., Maeder P., et al. The aetiology of posterior circulation infarcts: a prospective study using magnetic resonance imaging and magnetic resonance angiography. Neurology 43 (1993) 1528-1533
66. Ohama E., Ohara S., Ikuta F., et al. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 74 (1987) 226-233
67. Kuriyama M., Umezaki H., Fukuda Y., et al. Mitochondrial encephalomyopathy with lactatepyruvate elevation and brain infarctions. Neurology 34 (1984) 72-77
68. Schlaug G., Siewert B., Benfield A., et al. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 49 (1997) 113-119
69. Peng N.J., Liu R.S., Li J.Y., et al. Increased cerebral blood flow in MELAS shown by Tc-99m HMPOA brain SPECT. Neuroradiology 42 (2000) 26-29
70. Takahashi S., Tohgi H., Yonezawa H., et al. Cerebral blood flow and oxygen metabolism before and after a stroke-like episode in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). J Neurol Sci 158 (1998) 58-64
71. Leu(UUR) in patient with cluster headache. Lancet 344 (1994) 625
72. Leu(UUR) gene. Eur J Pediatr 155 (1996) 898-903
73. Vilarinho L., Maia C., Coelho T., et al. Heterogeneous presentation in Leigh syndrome. J Inherit Metab Dis 20 (1997) 704-705
74. Leu(UUR) mutation of mitochondrial DNA. Muscle Nerve 19 (1996) 187-190
75. Kuroiwa T., Kuwata T., Nakayama T., et al. Mitochondrial encephalomyopathy showing prominent microvacuolation and necrosis of intestinal smooth muscle cells: a case diagnosed by rectal biopsy. Acta Neuropathol 96 (1998) 86-90
76. Crimmins D.S., Morris J.G.L., Walker G.L., et al. Mitochondrial encephalomyopathy: variable clinical expression within a single kindred. J Neurol Neurosurg Psychiatry 56 (1993) 900-905
77. Okajima Y., Tanabe Y., Takayanagi M., et al. A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Heart 80 (1998) 292-295
78. Leu gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness. J Med Genet 32 (1995) 654-656
79. Leu(UUR) 3243 presenting as hypertrophic cardiomyopathy. Intern Med 34 (1995) 670-673
80. Leu(UUR) mutation in encephalomyopathy and cardiomyopathy. Biochem Biophys Res Commun 222 (1996) 201-207
81. Anan R., Nakagawa M., Miyata M., et al. Cardiac involvement in mitochondrial diseases-a study of 17 patients with documented mitochondrial defects. Circulation 91 (1995) 955-961
82. Sue C.M., Mitchell P., Crimmins D.S., et al. Pigmentary retinopathy associated with the mitochondrial DNA 3243 point mutation. Neurology 49 (1997) 1013-1017
83. Bird A.C., Bressler N.M., Bressler S.B., et al. An international classification and grading system for age-related macular degeneration. The international ARM epidemiological study group. Surv Ophthalmol 39 (1995) 367-374
84. Karvonen S.-L., Haapasaari K.-M., Kallioinen M., et al. Increased prevalence of vitiligo, but no evidence of premature ageing, in the skin of patients with bp 3243 mutation in mitochondrial DNA in the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome (MELAS). Br J Dermatol 140 (1999) 634-639
85. Horiguchi Y., Fujii T., and Imamura S. Purpuric cutaneous manifestations in mitochondrial encephalomyopathy. J Dermatol 18 (1991) 295-301
86. Fujii T., Okuno T., Masatoshi I., et al. MELAS of infantile onset: mitochondrial angiopathy or cytopathy?. J Neurol Sci 103 (1991) 37-41
87. Suzuki T., Koizumi J., Shiraishi H., et al. Mitochondrial encephalomyopathy (MELAS) with mental disorder CT, MRI, and SPECT findings. Neuroradiology 32 (1990) 74-76
88. Thomeer E.C., Verhoeven W., and Van de Vlasakker C.J.W. Psychiatric symptoms in MELAS; a case report. J Neurol Neurosurg Psychiatry 64 (1998) 692-693
89. Klopstock T., Jaksch M., and Gasser T. Age and cause of death in mitochondrial diseases. Neurology 53 (1999) 855
90. Leu A3243G point mutation: implications for pathogenesis. J Neurol Neurosurg Psychiatry 65 (1998) 233-240
91. Kendall B.E. Disorders of lysosomes, peroximes, and mitochondria. Am J Neuroradiol 13 (1992) 621-639
92. Lowenthal A. Striopallidodentate Calcifications. In: Vinken P.J., and Bruyn G.W. (Eds). Handbook of Clinical Neurology. (1986), Elsevier, Amsterdam 417-436
93. Toppet M., Telerman-Toppet N., Szliwowski H.B., et al. Oculocraniosomatic neuromuscular disease with hypoparathyroidism. Am J Dis Child 131 (1997) 437-441
94. Reynolds S.F., and Blass J.P. A possible mechanism for selective cerebellar damage in partial pyruvate dehydrogenase deficiency. Neurology 26 (1976) 625-628
95. Hasuo K., Tamura S., Yasumori K., et al. Computerized tomography and angiography in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes); report of three cases. Neuroradiology 29 (1987) 393-397
96. Matthews P.M., Andermann F., Silver K., et al. Proton MR spectroscopic characterisation of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 43 (1993) 2484-2490
97. Yamamoto T., Beppu H., and Tsubaki T. Mitochondrial encephalopathy: fluctuating symptoms and CT. Neurology 34 (1984) 1456-1460
98. Leu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology 41 (1991) 1663-1665
99. Love S., Nicoll A.R., and Kinrade E. Sequencing and quantitative assessment of mutant and wild-type mitochondrial DNA in paraffin sections from cases of MELAS. J Pathol 170 (1993) 9-14
100. Shoji Y., Sato W., Hayasaka K., et al. Tissue distribution of mutant mitochondrial DNA in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes. J Inherit Metab Dis 16 (1993) 27-30
101. Kishi M., Yamamura Y., Kuriharra T., et al. An autopsy case of mitochondrial encephalopathy: biochemical and electron microscopic studies of the brain. J Neurol Sci 86 (1988) 31-40
102. Ooiwa Y., Uematsu Y., Terada T., et al. Cerebral blood flow in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes. Stroke 24 (1993) 304-309
103. Goto Y. Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve 3 (1995) S107-S112
104. Sakuta R., and Nonaka I. Vascular involvement in mitochondrial myopathy. Ann Neurol 25 (1989) 594-601
105. Tokunaga M., Mita S., Sakuta R., et al. Increased mitochondrial DNA in blood vessels and ragged-red fibres in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS). Ann Neurol 33 (1993) 275-280
106. Hasegawa T., Matsuoka T., Goto Y., et al. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS). Ann Neurol 29 (1991) 601-605
107. Matsuoka T., Hasegawa T., and Nonaka I. Strongly succinate dehydrogenase-reactive blood vessels (SSV) in various neuromuscular diseases. Clin Neurol 32 (1992) 645-647
108. Barkovich A.J., Good W.V., Koch T.K., et al. Mitochondrial disorders: analysis of their clinical and imaging characteristics. Am J Neuroradiol 14 (1993) 1119-1137
109. 1H MRSI, MRI and neuropsychological testing. Proc Intl Soc Mag Reson Med 7 (1999) 49
110. De Volder A., Ghilain S., de Barsy T., et al. Brain metabolism in mitochondrial encephalopathy: a PET study. J Comput Assist Tomogr 12 (1988) 854-857
111. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348 (1990) 651-653
112. Kobayashi Y., Momoi M.Y., Tominaga K., et al. A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes). Biochem Biophys Res Commun 173 (1990) 816-822
113. Penisson-Besnier I., Reynier P., Asfar P., et al. Recurrent brain hematomas in MELAS associated with an ND5 gene mitochondrial mutation. Neurology 55 (2000) 317-318
114. Graf W.D., Sumi S.M., Copass M.K., et al. Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged-red fiber disease point mutation in mitochondrial DNA. Ann Neurol 33 (1993) 640-645
115. Hammans S.R., Sweeney M.G., Brockington M., et al. The mitochondrial DNA transfer RNALysA→G(8344) mutation and the syndrome of myoclonic epilepsy with ragged-red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 116 (1993) 617-632
116. Howell N., Kubacka I., Smith R., et al. Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease. Neurology 46 (1996) 219-222
117. Kobayashi Y., Momoi M.Y., Tominaga K., et al. Respiration-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS). Am J Hum Genet 49 (1991) 590-599
118. Boulet L., Karpati G., and Shoubridge E.A. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 51 (1992) 1187-1200
119. Holt I.J., Harding A.E., Petty R.K.H., et al. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 46 (1990) 428-433
120. Macmillan C., Lach B., and Shoubridge E.A. Variable distribution of mutant mitochondrial DNAs (tRNA(Leu[3243])) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation. Neurology 43 (1993) 1586-1590
121. Kobayashi Y., Ichihashi K., Ohta S., et al. The mutant mitochondrial genes in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) were selectively amplified through generations. J Inherit Metab Dis 15 (1992) 803-808
122. Martinuzzi A., Bartolomei L., Carrozzo R., et al. Correlation between clinical and molecular features in two MELAS families. J Neurol Sci 113 (1992) 222-229
123. Shiraiwa N., Ishii A., Iwamoto H., et al. Content of mutant mitochondrial DNA organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies. J Neurol Sci 120 (1993) 174-179
124. Liou C.W., Huang C.C., Chee E.C., et al. MELAS syndrome: correlation between clinical features and molecular genetic analysis. Acta Neurol Scand 90 (1994) 354-359
125. Campos Y., Bautista J., Gutierrez-Rivas E., et al. Clinical heterogeneity in two pedigrees with the 3243 bp tRNA(Leu(UUR)) mutation of mitochondrial DNA. Acta Neurol Scand 91 (1995) 62-65
126. Chinnery P.F., Howell N., Lightowlers R.N., et al. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain 121 (1998) 1889-1894
127. Tsairis P., Engel W.K., and Kark P. Familial myoclonic epilepsy syndrome associated with skeletal muscle mitochondrial abnormalities. Neurology 23 (1973) 408
128. Shoffner J.M., Lott M.T., Lezza A.M., et al. Myoclonic epilepsy and ragged-red fibre disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61 (1990) 931-937
129. Berkovic S.F., Carpenter S., Evans A., et al. Myoclonus epilepsy and ragged red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 112 (1989) 1231-1260
130. Tulinius M.H., Holme E., Kristiansson B., et al. Mitochondrial encephalomyopathies in childhood. II. Clinical manifestations and syndromes. J Pediatr 119 (1991) 251-259
131. Geny C., Cormier V., Meyrignac C., et al. Muscle mitochondrial DNA in encephalomyopathy and ragged red fibres: a Southern blot analysis and literature review. J Neurol 238 (1991) 171-176
132. Sweeney M.G., Hammans S.R., Duchen L.W., et al. Mitochondrial DNA mutation underlying Leigh's syndrome: clinical, pathological, biochemical, and genetic studies of a patient presenting with a progressive myoclonic epilepsy. J Neurol Sci 121 (1994) 57-65
133. Santorelli F.M., Tanji K., Shanske S., et al. The mitochondrial DNA A8344G mutation in Leigh syndrome revealed by analysis in paraffin-embedded sections: revisiting the past. Ann Neurol 44 (1998) 962-964
134. G(8344) mutation in Italian families with myoclonus, epilepsy and ragged red fibres (MERRF). Am J Hum Genet 48 (1991) 203-211
135. Enriquez J.A., Chomyn A., and Attardi G. MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination. Nat Genet 10 (1995) 47-55
136. Ozawa M., Nishino I., Horai S., et al. Myoclonus epilepsy associated with ragged-red fibres. a G-to-A mutation at nucleotide pair 8363 in mitochondrial tRNA(Lys) in two families. Muscle Nerve 20 (1997) 271-278
137. Tiranti V., Chariot P., Carella F., et al. Maternally inherited hearing loss, ataxia, and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum Mol Genet 4 (1995) 1421-1427
138. So N., Berkovic S.F., Andermann F., et al. Myoclonus epilepsy and ragged-red fibres (MERRF). 2. Electrophysiological studies and comparison with other progressive myoclonus epilepsies. Brain 112 (1989) 1261-1276
139. Rosing H.S., Hopkins L.C., Wallace D.C., et al. Maternally inherited mitochondrial myopathy and myoclonic epilepsy. Ann Neurol 17 (1985) 228-237
140. Shoffner J.M., Lott M.T., and Wallace D.C. MERRF: a model disease for understanding the principles of mitochondrial genetics. Rev Neurol 147 (1991) 431-435
141. Berkovic S.F., Andermann F., Shoubridge E.A., et al. Mitochondrial dysfunction in multiple symmetrical lipomatosis. Ann Neurol 29 (1991) 566-599
142. Takeda S., Wakabayashi K., Ohama E., et al. Neuropathology of myoclonus epilepsy associated with ragged red fibres (Fukuhara's disease). Acta Neuropathol 75 (1988) 433-440
143. Ortiz R., Newman N.J., Shoffner J.M., et al. Variable retinal and neurologic manifestations in patients harboring the mitochondrial DNA 8993 mutation. Arch Ophthalmol 111 (1993) 1525-1530
144. Fryer A., Appleton R., Sweeney M.G., et al. Mitochondrial DNA 8993 (NARP) mutation presenting with a heterogeneous phenotype including "cerebral palsy.". Arch Dis Child 71 (1994) 419-422
145. Makela-Bengs P., Soumalainene A., Majander A., et al. Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome. Paediatr Res 378 (1995) 634-639
146. Puddu P., Barboni P., Mantovani V., et al. Retinitis pigmentosa, ataxia, and mental retardation associated with mitochondrial DNA mutation in an Italian family. Br J Ophthalmol 77 (1993) 84-88
147. Uziel G., Moroni I., Lamantea E., et al. Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families. J Neurol Neurosurg Psychiatry 63 (1997) 16-22
148. Chowers I., Lerman-Sagie T., Elpeleg O.N., et al. Cone and rod dysfunction in the NARP syndrome. Br J Ophthalmol 83 (1999) 190-193
149. Tatuch Y., Christodoulou J., Feigenbaum A., et al. Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of mtDNA is high. Am J Hum Genet 50 (1992) 852-858
150. Ciafaloni E., Santorelli F.M., Shanske S., et al. Maternally inherited Leigh syndrome. J Pediatr 122 (1993) 419-422
151. Yoshinaga Y., Tatsuya O., Shunsuke O., et al. A T→G mutation at nucleotide pair 8993 in mitochondrial DNA in a patient with Leigh's syndrome. J Child Neurol 8 (1993) 129-133
152. Santorelli F.M., Shanske S., Macaya A., et al. The mutation at 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 34 (1993) 827-834
153. De Vries D.D., van Engelen B.G., Gabreëls F.J., et al. A second missense mutation in the ATPase 6 gene in Leigh's syndrome. Ann Neurol 34 (1993) 410-412
154. Santorelli F.M., Shanske S., Jain K.D., et al. A T→C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome. Neurology 44 (1994) 972-974
155. Cox G.B., Fimmel A.L., Gibson F., et al. The mechanism of ATP synthase: a reassessment of the function of the β and α subunit. Biochim Biophys Acta 849 (1986) 62-69
156. Boyer P.D. A perspective of the binding change mechanism for ATP synthesis. FASEB J 3 (1989) 2146-2178
157. Vazquez-Memije M.E., Shanske S., Santorelli F.M., et al. Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J Inherit Metab Dis 19 (1996) 43-50
158. Sembrano E., Barthlen G.M., Wallace S., et al. Polysomnographic findings in a patient with the mitochondrial encephalomyopathy NARP. Neurology 49 (1997) 1714-1717
159. Parfait B., de Lonlay P., von Kleist-Retzow J.C., et al. The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia. Eur J Pediatr 158 (1999) 55-58
160. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14 (1951) 216-221
161. Di Mauro S., and De Vivo D.C. Genetic heterogeneity in Leigh syndrome. Ann Neurol 40 (1996) 5-7
162. Van Erven P.M., Gabreels F.J., Ruitenbeek W., et al. Mitochondrial encephalomyopathy. Association with an NADH dehydrogenase deficiency. Arch Neurol 44 (1987) 775-778
163. Willems J.L., Monnens L.A., Trijbels J.M., et al. Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics 60 (1977) 850-857
164. Van Coster R., Lombes A., De Vivo D.C., et al. Cytochrome c oxidase-associated Leigh syndrome: phenotypic features and pathogenetic speculations. J Neurol Sci 104 (1991) 97-111
165. Kretzschmar H.A., De Armond S.J., Koch T.K., et al. Pyruvate dehydrogenase complex deficiency as a cause of subacute necrotising encephalopathy (Leigh disease). Pediatrics 79 (1987) 370-373
166. Baumgartner E.R., Suormala T.M., Wick H., et al. Biotinidase deficiency: a cause of subacute necrotising encephalomyelopathy (Leigh syndrome). Report of a case with lethal outcome. Pediatr Res 26 (1989) 260-266
167. Rahman S., Blok R.B., Dahl H.H., et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39 (1996) 343-351
168. Matthews P.M., Marchington D.R., Squier M., et al. Molecular genetic characterization of an X-linked form of Leigh's syndrome. Ann Neurol 33 (1993) 652-655
169. Loeffen J., Smeitink J., Triepels R., et al. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 6 (1998) 1598-1608
170. Bourgeron T., Rustin P., Chretien M., et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11 (1995) 144-149
171. Tiranti V., Hoertnagel K., Carrozzo R., et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 63 (1998) 1609-1621
172. Zhu Z., Yao J., Johns T., et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 20 (1998) 337-343
173. Sue C.M., Karadimas C., Checcarelli N., et al. Differential features of patients with mutations in two COX assembly genes, SURF-1 and SCO2. Ann Neurol 47 (2000) 589-595
174. Koga Y., Yoshino M., and Kato H. MELAS exhibits dominant negative effects on mitochondrial RNA processing. Ann Neurol 43 (1998) 835
175. Chalmers R.M., Lamont P.J., Nelson I., et al. A mitochondrial DNA tRNA(Val) point mutation associated with adult-onset Leigh syndrome. Neurology 49 (1997) 589-592
176. Yamamoto M., Clemens P.R., and Engel A.G. Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patients. Neurology 41 (1991) 1822-1828
177. Yamadori I., Kurose A., Kobayashi S., et al. Brain lesions of the Leigh-type distribution associated with a mitochondriopathy of Pearson's syndrome: light and electron microscopic study. Acta Neuropathol 84 (1992) 337-341
178. Morris A.A., Taanman J.W., Blake J., et al. Liver failure associated with mitochondrial DNA depletion. J Hepatol 28 (1998) 556-563
179. De Meirleir L., Seneca S., Lissens W., et al. Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 gene. Paediatr Neurol 13 (1995) 242-246
180. Thyagarajan D., Shanske S., Vazquez Memije M., et al. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 38 (1995) 468-472
181. Moraes C.T., Shanske S., Tritschler H.J., et al. MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial disease. Am J Hum Genet 48 (1991) 492-501
182. Taanman J.W., Bodnar A.G., Cooper J.M., et al. Molecular mechanisms in mitochondrial DNA depletion syndrome. Hum Mol Genet 6 (1997) 935-942
183. Vu T.H., Sciacco M., Tanji K., et al. Clinical manifestations of mitochondrial DNA depletion. Neurology 50 (1998) 1783-1790
184. Pons R., Andreetta F., Wang C.H., et al. Mitochondrial myopathy simulating spinal muscular atrophy. Pediatr Neurol 15 (1996) 153-258
185. Vu T.H., Tanji K., Holve S.A., et al. Navajo neurohepatopathy: a mitochondrial DNA depletion syndrome?. Hepatology 34 (2001) 116-120
186. Bodnar A.G., Cooper J.M., Holy I.J., et al. Nuclear complementation restores mtDNA levels in cultures cells from a patient with mtDNA depletion. Am J Hum Genet 53 (1993) 663-669
187. Bardosi A., Creutzfeldt W., DiMauro S., et al. Myo-neuro-gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome c oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol 74 (1987) 248-258
188. Hirano M., Silvestri G., Blake D.M., et al. Mitochondrial neuro-gastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44 (1994) 721-727
189. Nishino I., Spinazzola A., and Hirano M. Thymidine phosphorylase gene mutations in MNGIE: a human mitochondrial disorder. Science 283 (1999) 689-692
190. Harding A.E., and Sweeney M.G. Leber's Hereditary Optic Neuropathy. In: Schapira A., and DiMauro S. (Eds). Mitochondrial Disorders in Neurology. (1994), Butterworth-Heinemann, Oxford 181-198
191. Mackey D., and Howell N. A variant of Leber's hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet 51 (1992) 1218-1228
192. Howell N. Leber hereditary optic neuropathy: how do mitochondrial DNA mutations cause degeneration of the optic nerve?. J Bioenerg Biomembr 29 (1997) 165-173
193. Smith P.R., Cooper J.M., Govan G.G., et al. Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sci 122 (1994) 80-83
194. Larsson N.G., Andersen O., Holme E., et al. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol 30 (1991) 701-708
195. Bu X.D., and Rotter J.I. X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc Natl Acad Sci U S A 88 (1991) 8198-8202
196. Chalmers R.M., Davis M.B., Sweeney M.G., et al. Evidence against an X-linked visual susceptibility locus in Leber hereditary optic neuropathy. Am J Hum Genet 59 (1996) 103-108
197. Smith P.R., Cooper J.M., Govan G.G., et al. Antibodies to human optic nerve in Leber's hereditary optic neuropathy. J Neurol Sci 130 (1995) 134-138
198. Harding A.E., Sweeney M.G., Miller D.H., et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 115 (1992) 979-989
199. Jun A.S., Brown M.D., and Wallace D.C. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci U S A 91 (1994) 6206-6210
200. De Vries D.D., Went L.N., Bruyn G.W., et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 58 (1996) 703-711
201. Nikoskelainen E., Wanne O., and Dahl M. Pre-excitation syndrome and Leber's hereditary optic neuropathy. Lancet 1 (1985) 696
202. Hudgson P., Bradley W.G., and Jenkinson M. Familial mitochondrial myopathy: disordered oxidative metabolism in muscle fibres. J Neurol Sci 16 (1972) 343-370
203. Kamieniecka Z. Myopathies with abnormal mitochondria. A clinical, histological, and electro-physiological study. Acta Neurol Scand 55 (1977) 57-75
204. Koga Y., Nonaka I., Kobayashi H., et al. Findings in muscle in complex I (NADH Coenzyme Q reductase) deficiency. Ann Neurol 24 (1988) 749-756
205. Morgan-Hughes J.A., Cooper J.M., Schapira A., et al. The Mitochondrial Myopathies. Defects of the Respiratory Chain and Oxidative Phosphorylation System. In: Ellingson R.J., Murray N.M.F., and Halliday A.M. (Eds). The London Symposia. (1987), Elsevier, Amsterdam 103-114
206. Dalakas M.C., Illa I., Pezeshkpour G.H., et al. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322 (1990) 1098-1105
207. Dalakas M.C., Monzon M.E., Bernardini I., et al. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol 35 (1994) 483-487
208. Lai K.K., Gang D.L., Zawacki J.K., et al. Fulminant hepatic failure associated with 2′-3′-dideoxy-inosine (ddI). Ann Intern Med 115 (1991) 283-284
209. Carr A., and Cooper D.A. Adverse effects of antiretroviral therapy. Lancet 356 (2000) 1423-1430
210. Blanche S., Tardieu M., Rustin P., et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogs. Lancet 354 (1999) 1084-1089
211. Chalmers A.C., Greco C.M., and Miller R.G. Prognosis in AZT myopathy. Neurology 41 (1991) 1181-1184
212. Zupanc M.I., Moraes C.T., Shanske S., et al. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol 29 (1991) 680-683
213. Byrne E., Trounce I., Dennett X., et al. Progression from MERRF to MELAS phenotype in a patient with combined respiratory complex I and IV deficiencies. J Neurol Sci 88 (1988) 327-338
214. Prezant T.R., Agapian J.V., Bohlman M.C., et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4 (1993) 289-294
215. Reid F.M., Vernham G.A., and Jacobs H.T. A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum Mutat 3 (1994) 243-247
216. Oshima T, Ikeda K, Ueda N, et al. Sensorineural hearing loss with a mitochondrial gene point mutation is highly prevalent in Japan. In Association for Research in Otolaryngology. St Petersburg, Florida, 1999:11-99.
217. DiMauro S., and Bonilla E. Mitochondrial Encephalomyopathies. In: Rosenberg R.N., Prusiner S.B., DiMauro S., and Barchi R.L. (Eds). The Molecular and Genetic Basis of Neurological Disease. (1997), Butterworth-Heinemann, Boston 201-235
218. Estivill X., Govea N., Barcelo E., et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am J Hum Genet 62 (1998) 27-35
219. Bykhovskaya Y., Estivill X., Taylor K., et al. Candidate locus for a nuclear modifier gene for maternally inherited deafness. Am J Hum Genet 66 (2000) 1905-1910
220. Guan M.X., Fischel-Ghodsian N., and Attardi G. Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation. Hum Mol Genet 5 (1996) 963-971
221. Chinnery P.F., Elliot C., Green G.R., et al. The spectrum of hearing loss due to mitochondrial DNA defects. Brain 123 (2000) 82-92
222. Kearns T.P., and Sayre G.P. Retinitis pigmentosa, external ophthalmoplegia, and complete heart block; unusual syndrome with histologic study in one of two cases. Arch Ophthalmol 60 (1958) 280-289
223. Eagle R.C., Hedges T.R., and Yanoff M. The atypical pigmentary retinopathy of Kearns-Sayre syndrome. Ophthalmology 89 (1982) 1433-1440
224. Mullie M.A., Harding A.E., Petty R.K.H., et al. The retinal manifestations of mitochondrial myopathy. Arch Ophthalmol 103 (1985) 1825-1830
225. Bosche J., Hammerstein W., Neuen-Jacob E., et al. Variation in retinal changes and muscle pathology in mitochondriopathies. Graefes Arch Clin Exp Ophthalmol 227 (1989) 578-583
226. Chang T.S., Johns D.R., Walker D., et al. Ocular clinicopathologic study of the mitochondrial encephalomyopathy overlap syndrome. Arch Ophthalmol 111 (1993) 1254-1262
227. Munnich A., Rotig A., Chretien D., et al. Clinical presentations and laboratory investigations in respiratory chain deficiency. Eur J Paediatr 155 (1996) 262-274
228. Turner L.F., Kaddoura S., Harrington D., et al. Mitochondrial DNA in idiopathic cardiomyopathy. Eur Heart J 19 (1998) 1725-1729
229. Moraes C.T., Ciacci F., Silvestri G., et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 3 (1993) 43-50
230. Pastores G.M., Santorelli F.M., Shanske S., et al. Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial DNA point mutation (T8993G). Am J Med Genet 50 (1994) 265-271
231. Takei Y., Ikeda S., Yanagisawa N., et al. Multiple mitochondrial DNA deletions in a patient with mitochondrial myopathy and cardiomyopathy but no ophthalmoplegia. Muscle Nerve 18 (1995) 1321-1325
232. Soumalainen A., Paetau A., Leinonen H., et al. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 340 (1992) 1319-1320
233. Bohlega S., Tanji K., Santorelli F.M., et al. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 46 (1996) 1329-1334
234. Sengers R.C., Trijbels J.M., Willems J.L., et al. Congenital cataract and mitochondrial myopathy of skeletal and heart muscle associated with lactic acidosis after exercise. J Paediatr 86 (1975) 873-880
235. Smeitink J., Huizing M., Ruitenbeek W., et al. Adenine nucleotide translocator deficiency in a patient with fatal congenital cardiomyopathy, cataract and mitochondrial myopathy. J Inherit Metab Dis 20 (1997) 7
236. Kaukonen J., Zeviani M., Comi G.P., et al. A third locus predisposing to multiple deletions mtDNA in autosomal dominant progressive external ophthalmoplegia. Am J Hum Genet 65 (1999) 256-261
237. Graham B.H., Waymire K.G., Cottrell B., et al. A mouse model for mitochondrial myopathy and car-diomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 16 (1997) 226-234
238. Pearson H.A., Lobel J.S., Kocoshis S.A., et al. A new syndrome of refractory sideroblastic anaemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Paediatr 95 (1979) 976-984
239. Rotig A., Colonna M., Bonnefont J.P., et al. Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet 1 (1989) 902-903
240. Bernes S.M., Bacino C., Prezant T.R., et al. Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome. J Paediatr 123 (1993) 598-602
241. Rotig A., Bourgeron T., Chretien D., et al. Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 4 (1995) 1327-1330
242. Larsson N.G., Holme E., Kristiansson B., et al. Progressive increase of the mutated mitochondrial DNA fraction in the Kearns-Sayre syndrome. Paediatr Res 28 (1990) 131-136
243. Gattermann N., Retzlaff S., Wang Y.L., et al. A heteroplasmic point mutation of mitochondrial tRNALeu(CUN) in non-lymphoid haemopoietic cell lineages from a patient with acquired idiopathic sideroblastic anaemia. Br J Haematol 93 (1996) 845-855
244. Gattermann N., Retzlaff S., Wang Y.L., et al. Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anaemia. Br J Haematol 90 (1997) 4961-4972
245. Tuckfield A., Ratnaike S., Hussein S., et al. A novel form of hereditary sideroblastic anaemia with macrocytosis. Br J Haematol 97 (1997) 279-285
246. Casademont J., Barrientos A., Cardellach F., et al. Multiple deletions of mtDNA in two brothers with sideroblastic anaemia and mitochondrial myopathy and in their asymptomatic mother. Hum Mol Genet 3 (1994) 1945-1949
247. Inbal A., Avissar N., Shaklai M., et al. Myopathy, lactic acidosis, and sideroblastic anaemia: a new syndrome. Am J Med Genet 55 (1995) 372-378
248. Niaudet P., and Rotig A. Renal involvement in mitochondrial cytopathies. Paediatr Nephrol 10 (1996) 268-373
249. Goto Y., Itami N., Kajii N., et al. Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. J Paediatr 116 (1990) 904-910
250. Kadowaki H., Tobe K., Mori Y., et al. Mitochondrial gene mutation and insulin-dependent type of diabetes mellitus. Lancet 341 (1993) 893-894
251. Rotig A., Cormier V., Chatelain P., et al. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300). J Clin Invest 91 (1993) 1095-1098
252. Barrientos A., Volpini V., Casademont J., et al. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J Clin Invest 97 (1996) 1570-1576
253. Verma A., Picolli D.A., Bonilla E., et al. A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res 42 (1997) 448-454
254. Cormier Daire V., Bonnefont J.P., Rustin P., et al. Mitochondrial DNA rearrangements with onset as chronic diarrhea with villous atrophy. J Pediatr 124 (1994) 63-70
255. Cormier Daire V., Chretien D., Rustin P., et al. Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation. J Pediatr 130 (1997) 817-822
256. Jackson M.J., Schaefer J.A., Johnson M.A., et al. Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain 118 (1995) 339-357
257. Schwartz W.J., Hutchinson H.T., and Berg B.O. Computerized tomography in subacute necrotizing encephalomyelopathy (Leigh disease). Ann Neurol 10 (1981) 268-271
258. Koch T.K., Yee M.H., Hutchinson H.T., et al. Magnetic resonance imaging in subacute necrotizing encephalomyelopathy (Leigh disease). Ann Neurol 19 (1986) 605-607
259. Wray S.H., Provenzale J.M., Johns D.R., et al. MRI of the brain in mitochondrial myopathy. Am J Neuroradiol 16 (1995) 1167-1173
260. Valanne L., Ketonen L., Majander A., et al. Neuroradiologic findings in children with mitochondrial disorders. Am J Neuroradiol 19 (1998) 369-377
261. Matthews P.M., Allaire C., Shoubridge E.A., et al. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology 41 (1991) 114-120
262. Tukinius M.H., and Hagne I. EEG findings in children and adolescents with mitochondrial encephalomyopathies: a study of 25 cases. Brain Dev 13 (1991) 167-173
263. Chu C.C., Huang C.C., Fang W., et al. Peripheral neuropathy in mitochondrial encephalomyopathies. Eur Neurol 37 (1997) 110-115
264. Müller-Höcker J. Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm in man without muscular disease: an age related alteration. J Neurol Sci 100 (1990) 14-21
265. Santorelli F.M., Tanji K., Kulikova R., et al. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem Biophys Res Commun 238 (1997) 326-328
266. Hammans S.R., Sweeney M.G., Wicks D.A., et al. A molecular genetic study of focal histochemical defects in mitochondrial encephalomyopathies. Brain 115 (1992) 343-365 [Published erratum appears in pt following
267. Brain 116 1 (1993) 306
268. Moraes C.T., Andreetta F., Bonilla E., et al. Replication-competent human mitochondrial DNA lacking the heavy-strand promoter region. Mol Cell Biol 11 (1991) 1631-1642
269. Moraes C.T., Ricci E., Petruzella V., et al. Molecular analysis of muscle pathology associated with the mitochondrial DNA deletions. Nat Genet 1 (1992) 359-367
270. Shoubridge E.A., Karpati G., and Hastings K. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fibre segments in mitochondrial disease. Cell 62 (1990) 43
271. Stadhouders A.M., and Sengers R.C. Morphological observations in skeletal muscle from patients with a mitochondrial myopathy. J Inherit Metab Dis 10 1 (1987) 62-80
272. Dubowitz V. Muscle Biopsy: A Practical Approach. 2nd ed (1985), Balliére Tindall, London
273. Moraes C.T., Ricci E., Bonilla E., et al. The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet 50 (1992) 934-949
274. Bindoff L.A., Desnuelle C., Birch-Machin A., et al. Multiple defects of the mitochondrial respiratory chain in a mitochondrial encephalopathy (MERRF): a clinical, biochemical and molecular study. J Neurol Sci 102 (1991) 17-24
275. Seibel P., Degoul F., Bonne G., et al. Genetic, biochemical and pathophysiological characterization of a familial mitochondrial encephalomyopathy (MERRF). J Neurol Sci 105 (1991) 217-224
276. 1 complex in mitochondrial disease. J Bioenerg Biomembr 20 (1988) 325-352